LIF-Dependent Signaling: New Pieces in the Lego

Stem Cell Reviews and Reports

Volumn 8, Issue 1, 2012, Pages 1-15

  Mathieu, Marie Emmanuelle ^a,b,c   Saucourt, Claire ^a,b,d   Mournetas, Virginie ^a,b,e   Gauthereau, Xavier ^a,b,c   Thézé, Nadine ^a,b,c   Praloran, Vincent ^a,b,c   Thiébaud, Pierre ^a,b,c   Bœuf, Hélène ^a,b,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CNRS   (France)

^c CNRS Bordeaux Segalen University   (France)

^d IRTH/Cell Prothera   (France)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Chromatin; EVO DEVO; IL6; LIF cytokine; miRNA; p53; Pleiotropy; Reprogrammation; Signaling; Stem cells

Indexed keywords

LEUKEMIA INHIBITORY FACTOR; LIF PROTEIN, HUMAN; PROTEIN P53; TRANSCRIPTION FACTOR;

ANIMAL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PLEIOTROPY; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC PLEIOTROPY; HUMANS; LEUKEMIA INHIBITORY FACTOR; SIGNAL TRANSDUCTION; STEM CELLS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EUTHERIA; MAMMALIA; MURINAE;

EID: 84857653315     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-011-9261-7     Document Type: Review

References (208)

1. Taupin, J. L., Pitard, V., Dechanet, J., Miossec, V., Gualde, N., & Moreau, J. F. (1998). Leukemia inhibitory factor: part of a large ingathering family. International Reviews of Immunology, 16(3-4), 397-426.
2. Metcalf, D. (2003). The unsolved enigmas of leukemia inhibitory factor. Stem Cells, 21(1), 5-14.
3. Moreau, J. F., Donaldson, D. D., Bennett, F., Witek-Giannotti, J., Clark, S. C., & Wong, G. G. (1988). Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells. Nature, 336(6200), 690-692.
4. Smith, A. G., Nichols, J., Robertson, M., & Rathjen, P. D. (1992). Differentiation inhibiting activity (DIA/LIF) and mouse development. Developmental Biology, 151(2), 339-351.
5. Gough, N. M., Gearing, D. P., King, J. A., Willson, T. A., Hilton, D. J., Nicola, N. A., et al. (1988). Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukemia-inhibitory factor. Proceedings of the National Academy of Sciences of the United States of America, 85(8), 2623-2627.
6. Shellard, J., Perreau, J., & Brûlet, P. (1996). Role of leukemia inhibitory factor during mammalian development. European Cytokine Network, 7(4), 699-712.
7. Trouillas, M., Saucourt, C., Guillotin, B., Gauthereau, X., Taupin, J., Moreau, J.,(2009). The LIF cytokine: towards adulthood. European Cytokine Network, 20(2), 51-62.
8. Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M., Müller-Newen, G., & Schaper, F. (2003). Principles of interleukin (IL)-6-type cytokine signalling and its regulation. The Biochemical Journal, 374(Pt 1), 1-20.
9. Murakami, M., Kamimura, D., & Hirano, T. (2004). New IL-6 (gp130) family cytokine members, CLC/NNT1/BSF3 and IL-27. Growth Factors, 22(2), 75-77.
10. Hermanns, H. M., Müller-Newen, G., Heinrich, P. C., & Haan, S. (2005). Bow to your partner for signaling. Nature Structural & Molecular Biology, 12(6), 476-478.
11. Rousseau, F., Chevalier, S., Guillet, C., Ravon, E., Diveu, C., Froger, J., et al. (2008). Ciliary neurotrophic factor, cardiotrophin-like cytokine, and neuropoietin share a conserved binding site on the ciliary neurotrophic factor receptor alpha chain. The Journal of Biological Chemistry, 283(44), 30341-30350.
12. Rousseau, F., Basset, L., Froger, J., Dinguirard, N., Chevalier, S., Gascan, H. (2010). IL-27 structural analysis demonstrates similarities with ciliary neurotrophic factor (CNTF) and leads to the identification of antagonistic variants. Proceedings of the National Academy of Sciences of the United States of America.
13. Gearing, D. P. (1993). The leukemia inhibitory factor and its receptor. Advances in Immunology, 53, 31-58.
14. Blanchard, F., Duplomb, L., Wang, Y., Robledo, O., Kinzie, E., Pitard, V., et al. (2000). Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase. The Journal of Biological Chemistry, 275(37), 28793-28801.
15. Gao, W., Thompson, L., Zhou, Q., Putheti, P., Fahmy, T. M., Strom, T. B., et al. (2009). Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6. Cell Cycle, 8(9), 1444-1450.
16. Blanchard, F., Duplomb, L., Raher, S., Vusio, P., Hoflack, B., Jacques, Y., et al. (1999). Mannose 6-Phosphate/Insulin-like growth factor II receptor mediates internalization and degradation of leukemia inhibitory factor but not signal transduction. The Journal of Biological Chemistry, 274(35), 24685-24693.
17. Larsen, J. V., Hansen, M., Møller, B., Madsen, P., Scheller, J., Nielsen, M., et al. (2010). Sortilin facilitates signaling of ciliary neurotrophic factor and related helical type 1 cytokines targeting the gp130/leukemia inhibitory factor receptor beta heterodimer. Molecular and Cellular Biology, 30(17), 4175-4187.
18. Bhatt, H., Brunet, L. J., & Stewart, C. L. (1991). Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation. Proceedings of the National Academy of Sciences of the United States of America, 88(24), 11408-11412.
19. Stewart, C. L., Kaspar, P., Brunet, L. J., Bhatt, H., Gadi, I., Köntgen, F., et al. (1992). Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature, 359(6390), 76-79.
20. Escary, J. L., Perreau, J., Duménil, D., Ezine, S., & Brûlet, P. (1993). Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature, 363(6427), 361-364.
21. Kritikou, E. A., Sharkey, A., Abell, K., Came, P. J., Anderson, E., Clarkson, R. W., et al. (2003). A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development, 130, 3459-3468.
22. Bauer, S., & Patterson, P. H. (2006). Leukemia inhibitory factor promotes neural stem cell self-renewal in the adult brain. The Journal of Neuroscience, 26(46), 12089-12099.
23. Oshima, K., Teo, D. T. W., Senn, P., Starlinger, V., & Heller, S. (2007). LIF promotes neurogenesis and maintains neural precursors in cell populations derived from spiral ganglion stem cells. BMC Developmental Biology, 7, 112.
24. Simamura, E., Shimada, H., Higashi, N., Uchishiba, M., Otani, H., & Hatta, T. (2010). Maternal leukemia inhibitory factor (LIF) promotes fetal neurogenesis via a LIF-ACTH-LIF signaling relay pathway. Endocrinology, 151(4), 1853-1862.
25. Hunt, L. C., Tudor, E. M., & White, J. D. (2010). Leukemia inhibitory factor-dependent increase in myoblast cell number is associated with phosphotidylinositol 3-kinase-mediated inhibition of apoptosis and not mitosis. Experimental Cell Research, 316(6), 1002-1009.
26. Spangenburg, E. E., & Booth, F. W. (2002). Multiple signaling pathways mediate LIF-induced skeletal muscle satellite cell proliferation. American Journal of Physiology. Cell Physiology, 283(1), C204-C211.
27. Broholm, C., & Pedersen, B. K. (2010). Leukaemia inhibitory factor-an exercise-induced myokine. Exercise Immunology Review, 16, 77-85.
28. Bozec, A., Bakiri, L., Hoebertz, A., Eferl, R., Schilling, A. F., Komnenovic, V., et al. (2008). Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature, 454(7201), 221-225.
29. Sendtner, M., Götz, R., Holtmann, B., Escary, J. L., Masu, Y., Carroll, P., et al. (1996). Cryptic physiological trophic support of motoneurons by LIF revealed by double gene targeting of CNTF and LIF. Current Biology, 6(6), 686-694.
30. Holtmann, B., Wiese, S., Samsam, M., Grohmann, K., Pennica, D., Martini, R., et al. (2005). Triple knock-out of CNTF, LIF, and CT-1 defines cooperative and distinct roles of these neurotrophic factors for motoneuron maintenance and function. The Journal of Neuroscience, 25(7), 1778-1787.
31. Aghajanova, L. (2010). Update on the role of leukemia inhibitory factor in assisted reproduction. Current Opinion in Obstetrics & Gynecology, 22(3), 213-219.
32. Slaets, H., Hendriks, J. J. A., Stinissen, P., Kilpatrick, T. J., & Hellings, N. (2010). Therapeutic potential of LIF in multiple sclerosis. Trends in Molecular Medicine, 16(11), 493-500.
33. Hu, W., Feng, Z., Teresky, A. K., & Levine, A. J. (2007). p53 regulates maternal reproduction through LIF. Nature, 450(7170), 721-724.
34. Hu, W., Feng, Z., Atwal, G. S., & Levine, A. J. (2008). p53: a new player in reproduction. Cell Cycle, 7(7), 848-852.
35. Stewart, C. L. (2007). Reproduction: the unusual suspect. Nature, 450(7170), 619.
36. Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., et al. (2009). Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature, 460(7259), 1140-1144.
37. Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., et al. (2009). Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature, 460(7259), 1132-1135.
38. Liu, Y., Hoya-Arias, R., & Nimer, S. D. (2009). The role of p53 in limiting somatic cell reprogramming. Cell Research, 19(11), 1227-1228.
39. Marión, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., et al. (2009). A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature, 460(7259), 1149-1153.
40. Menendez, S., Camus, S., & Belmonte, J. C. I. (2010). p53: guardian of reprogramming. Cell Cycle, 9(19), 3887-3891.
41. Li, H., Collado, M., Villasante, A., Strati, K., Ortega, S., Cañamero, M., et al. (2009). The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature, 460(7259), 1136-1139.
42. Hilton, D. J. (1992). LIF: lots of interesting functions. Trends in Biochemical Sciences, 17(2), 72-76.
43. Lim, W. A., & Pawson, T. (2010). Phosphotyrosine signaling: evolving a new cellular communication system. Cell, 142(5), 661-667.
44. Ingley, E. (2008). Src family kinases: regulation of their activities, levels and identification of new pathways. Biochimica et Biophysica Acta, 1784(1), 56-65.
45. Yagil, Z., Nechushtan, H., Kay, G., Yang, C. M., Kemeny, D. M., & Razin, E. (2010). The enigma of the role of protein inhibitor of activated STAT3 (PIAS3) in the immune response. Trends in Immunology, 31(5), 199-204.
46. Smith, A. G. (2001). Embryo-derived stem cells: of mice and men. Annual Review of Cell and Developmental Biology, 17, 435-462.
47. Niwa, H. (2007). How is pluripotency determined and maintained? Development, 134(4), 635-646.
48. Bourillot, P., Aksoy, I., Schreiber, V., Wianny, F., Schulz, H., Hummel, O., et al. (2009). Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog. Stem Cells, 27(8), 1760-1771.
49. Ura, H., Usuda, M., Kinoshita, K., Sun, C., Mori, K., Akagi, T., et al. (2008). STAT3 and Oct-3/4 control histone modification through induction of Eed in embryonic stem cells. The Journal of Biological Chemistry, 283(15), 9713-9723.
50. Boeuf, H., Hauss, C., Graeve, F. D., Baran, N., & Kedinger, C. (1997). Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells. The Journal of Cell Biology, 138(6), 1207-1217.
51. Matsuda, T., Nakamura, T., Nakao, K., Arai, T., Katsuki, M., Heike, T., et al. (1999). STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. The EMBO Journal, 18(15), 4261-4269.
52. Minami, M., Inoue, M., Wei, S., Takeda, K., Matsumoto, M., Kishimoto, T., et al. (1996). STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proceedings of the National Academy of Sciences of the United States of America, 93(9), 3963-3966.
53. Yoshida, T., Iwamoto, T., Adachi, K., Yokota, T., Miyake, Y., & Hamaguchi, M. (2005). Functional analysis of the effect of forced activation of STAT3 on M1 mouse leukemia cells. International Journal of Molecular Medicine, 15(2), 269-275.
54. Yamanaka, Y., Nakajima, K., Fukada, T., Hibi, M., & Hirano, T. (1996). Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. The EMBO Journal, 15(7), 1557-1565.
55. Silver, J. S., & Hunter, C. A. (2010). gp130 at the nexus of inflammation, autoimmunity, and cancer. Journal of Leukocyte Biology, 88(6), 1145-1156.
56. Fischer, P., Lehmann, U., Sobota, R. M., Schmitz, J., Niemand, C., Linnemann, S., et al. (2004). The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling. The Biochemical Journal, 378(Pt 2), 449-460.
57. Lin, C., Jackson, A. L., Guo, J., Linsley, P. S., & Eisenman, R. N. (2009). Myc-regulated microRNAs attenuate embryonic stem cell differentiation. The EMBO Journal, 28(20), 3157-3170.
58. Tarantino, C., Paolella, G., Cozzuto, L., Minopoli, G., Pastore, L., Parisi, S., et al. (2010). miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells. The FASEB Journal, 24(9), 3255-3263.
59. Oskowitz, A. Z., Lu, J., Penfornis, P., Ylostalo, J., McBride, J., Flemington, E. K., et al. (2008). Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression. Proceedings of the National Academy of Sciences of the United States of America, 105(47), 18372-18377.
60. Hao, J., Li, T., Qi, X., Zhao, D., & Zhao, G. (2006). WNT/beta-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Developmental Biology, 290(1), 81-91.
61. Ogawa, K., Nishinakamura, R., Iwamatsu, Y., Shimosato, D., & Niwa, H. (2006). Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. Biochemical and Biophysical Research Communications, 343(1), 159-166.
62. Boiani, M., & Schöler, H. R. (2005). Regulatory networks in embryo-derived pluripotent stem cells. Nature Reviews. Molecular Cell Biology, 6(11), 872-884.
63. Pera, M. F., & Tam, P. P. L. (2010). Extrinsic regulation of pluripotent stem cells. Nature, 465(7299), 713-720.
64. Kochegarov, A. (2009). Small molecules for stem cells. Expert Opinion on Therapeutic Patents, 19(3), 275-281.
65. Niwa, H. (2010). Mouse ES cell culture system as a model of development. Development, Growth & Differentiation, 52(3), 275-283.
66. Silva, J., & Smith, A. (2008). Capturing pluripotency. Cell, 132(4), 532-536.
67. Ying, Q., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., et al. (2008). The ground state of embryonic stem cell self-renewal. Nature, 453(7194), 519-523.
68. Chambers, I., & Tomlinson, S. R. (2009). The transcriptional foundation of pluripotency. Development, 136(14), 2311-2322.
69. Yang, W., Wei, W., Shi, C., Zhu, J., Ying, W., Shen, Y., et al. (2009). Pluripotin combined with leukemia inhibitory factor greatly promotes the derivation of embryonic stem cell lines from refractory strains. Stem Cells, 27(2), 383-389.
70. Chen, L., Yang, M., Dawes, J., & Khillan, J. S. (2007). Suppression of ES cell differentiation by retinol (vitamin A) via the overexpression of Nanog. Differentiation, 75(8), 682-693.
71. Chen, L., & Khillan, J. S. (2010). A novel signaling by vitamin A/retinol promotes self renewal of mouse embryonic stem cells by activating PI3K/Akt signaling pathway via insulin-like growth factor-1 receptor. Stem Cells, 28(1), 57-63.
72. Chazaud, C., Yamanaka, Y., Pawson, T., & Rossant, J. (2006). Early lineage segregation between epiblast and primitive endoderm in mouse blastocysts through the Grb2-MAPK pathway. Developmental Cell, 10(5), 615-624.
73. Carter, M. G., Stagg, C. A., Falco, G., Yoshikawa, T., Bassey, U. C., Aiba, K., et al. (2008). An in situ hybridization-based screen for heterogeneously expressed genes in mouse ES cells. Gene Expression Patterns, 8, 181-198.
74. Toyooka, Y., Shimosato, D., Murakami, K., Takahashi, K., & Niwa, H. (2008). Identification and characterization of subpopulations in undifferentiated ES cell culture. Development, 135, 909-918.
75. Kim, M. O., Lee, Y. J., & Han, H. J. (2010). Involvement of Cx43 phosphorylation in 5′-N-ethylcarboxamide-induced migration and proliferation of mouse embryonic stem cells. Journal of Cellular Physiology, 224(1), 187-194.
76. Todorova, M. G., Soria, B., & Quesada, I. (2008). Gap junctional intercellular communication is required to maintain embryonic stem cells in a non-differentiated and proliferative state. Journal of Cellular Physiology, 214(2), 354-362.
77. Wörsdörfer, P., Maxeiner, S., Markopoulos, C., Kirfel, G., Wulf, V., Auth, T., et al. (2008). Connexin expression and functional analysis of gap junctional communication in mouse embryonic stem cells. Stem Cells, 26(2), 431-439.
78. Wong, R. C. B., Pera, M. F., & Pébay, A. (2008). Role of gap junctions in embryonic and somatic stem cells. Stem Cell Reviews, 4(4), 283-292.
79. Saito, R., Yamasaki, T., Nagai, Y., Wu, J., Kajiho, H., Yokoi, T., et al. (2009). CrxOS maintains the self-renewal capacity of murine embryonic stem cells. Biochemical and Biophysical Research Communications, 390(4), 1129-1135.
80. Lian, I., Kim, J., Okazawa, H., Zhao, J., Zhao, B., Yu, J., et al. (2010). The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes & Development, 24(11), 1106-1118.
81. Fan, Y., Melhem, M. F., & Chaillet, J. R. (1999). Forced expression of the homeobox-containing gene Pem blocks differentiation of embryonic stem cells. Developmental Biology, 210(2), 481-496.
82. Lim, L. S., Loh, Y., Zhang, W., Li, Y., Chen, X., Wang, Y., et al. (2007). Zic3 is required for maintenance of pluripotency in embryonic stem cells. Molecular Biology of the Cell, 18(4), 1348-1358.
83. Lim, L. S., Hong, F. H., Kunarso, G., & Stanton, L. W. (2010). The pluripotency regulator Zic3 is a direct activator of the Nanog promoter in ESCs. Stem Cells, 28(11), 1961-1969.
84. Galan-Caridad, J. M., Harel, S., Arenzana, T. L., Hou, Z. E., Doetsch, F. K., Mirny, L. A., et al. (2007). Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell, 129(2), 345-357.
85. Mu, W., Munroe, R. J., Barker, A. K., & Schimenti, J. C. (2010). PDCD2 is essential for inner cell mass development and embryonic stem cell maintenance. Developmental Biology, 347(2), 279-288.
86. Amleh, A., Nair, S. J., Sun, J., Sutherland, A., Hasty, P., & Li, R. (2009). Mouse cofactor of BRCA1 (Cobra1) is required for early embryogenesis. PLoS ONE, 4(4), e5034.
87. Hu, G., Kim, J., Xu, Q., Leng, Y., Orkin, S. H., & Elledge, S. J. (2009). A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes & Development, 23(7), 837-848.
88. Ding, L., Paszkowski-Rogacz, M., Nitzsche, A., Slabicki, M. M., Heninger, A., de Vries, I., et al. (2009). A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity. Cell Stem Cell, 4(5), 403-415.
89. Ivanova, N., Dobrin, R., Lu, R., Kotenko, I., Levorse, J., DeCoste, C., et al. (2006). Dissecting self-renewal in stem cells with RNA interference. Nature, 442(7102), 533-538.
90. Loh, Y., Zhang, W., Chen, X., George, J., & Ng, H. (2007). Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes & Development, 21(20), 2545-2557.
91. Gaspar-Maia, A., Alajem, A., Polesso, F., Sridharan, R., Mason, M. J., Heidersbach, A., et al. (2009). Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature, 460(7257), 863-868.
92. Dejosez, M., Krumenacker, J. S., Zitur, L. J., Passeri, M., Chu, L., Songyang, Z., et al. (2008). Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells. Cell, 133(7), 1162-1174.
93. Dejosez, M., Levine, S. S., Frampton, G. M., Whyte, W. A., Stratton, S. A., Barton, M. C., et al. (2010). Ronin/Hcf-1 binds to a hyperconserved enhancer element and regulates genes involved in the growth of embryonic stem cells. Genes & Development, 24(14), 1479-1484.
94. Smith, K. N., Singh, A. M., & Dalton, S. (2010). Myc represses primitive endoderm differentiation in pluripotent stem cells. Cell Stem Cell, 7(3), 343-354.
95. Tay, Y., Zhang, J., Thomson, A. M., Lim, B., & Rigoutsos, I. (2008). MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature, 455, 1124-1128.
96. Bernstein, E., Kim, S. Y., Carmell, M. A., Murchison, E. P., Alcorn, H., Li, M. Z., et al. (2003). Dicer is essential for mouse development. Nature Genetics, 35(3), 215-217.
97. Kanellopoulou, C., Muljo, S. A., Kung, A. L., Ganesan, S., Drapkin, R., Jenuwein, T., et al. (2005). Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes & Development, 19(4), 489-501.
98. Murchison, E. P., Partridge, J. F., Tam, O. H., Cheloufi, S., & Hannon, G. J. (2005). Characterization of Dicer-deficient murine embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 102(34), 12135-12140.
99. Babiarz, J. E., Ruby, J. G., Wang, Y., Bartel, D. P., & Blelloch, R. (2008). Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. Genes & Development, 22(20), 2773-2785.
100. Wang, Y., Medvid, R., Melton, C., Jaenisch, R., & Blelloch, R. (2007). DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nature Genetics, 39, 380-385.
101. Wang, Y., Baskerville, S., Shenoy, A., Babiarz, J. E., Baehner, L., & Blelloch, R. (2008). Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nature Genetics, 40, 1478-1483.
102. Niwa, H., Miyazaki, J., & Smith, A. G. (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nature Genetics, 24(4), 372-376.
103. Rizzino, A. (2008). Transcription factors that behave as master regulators during mammalian embryogenesis function as molecular rheostats. The Biochemical Journal, 411(2), e5-e7.
104. Kopp, J. L., Ormsbee, B. D., Desler, M., & Rizzino, A. (2008). Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells, 26(4), 903-911.
105. Trouillas, M., Saucourt, C., Guillotin, B., Gauthereau, X., Ding, L., Buchholz, F., et al. (2009). Three LIF-dependent signatures and gene clusters with atypical expression profiles, identified by transcriptome studies in mouse ES cells and early derivatives. BMC Genomics, 10, 73.
106. Palmqvist, L., Glover, C. H., Hsu, L., Lu, M., Bossen, B., Piret, J. M., et al. (2005). Correlation of murine embryonic stem cell gene expression profiles with functional measures of pluripotency. Stem Cells, 23(5), 663-680.
107. Schulz, H., Kolde, R., Adler, P., Aksoy, I., Anastassiadis, K., Bader, M., et al. (2009). The FunGenES database: a genomics resource for mouse embryonic stem cell differentiation. PLoS ONE, 4(9), e6804.
108. Loh, Y., Wu, Q., Chew, J., Vega, V. B., Zhang, W., Chen, X., et al. (2006). The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nature Genetics, 38(4), 431-440.
109. Cinelli, P., Casanova, E. A., Uhlig, S., Lochmatter, P., Matsuda, T., Yokota, T., et al. (2008). Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. BMC Developmental Biology, 8, 57.
110. Storm, M. P., Kumpfmueller, B., Thompson, B., Kolde, R., Vilo, J., Hummel, O., et al. (2009). Characterization of the phosphoinositide 3-kinase-dependent transcriptome in murine embryonic stem cells: identification of novel regulators of pluripotency. Stem Cells, 27(4), 764-775.
111. Rathjen, P. D., Nichols, J., Toth, S., Edwards, D. R., Heath, J. K., & Smith, A. G. (1990). Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations. Genes & Development, 4(12B), 2308-2318.
112. Burdon, T., Stracey, C., Chambers, I., Nichols, J., & Smith, A. (1999). Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Developmental Biology, 210(1), 30-43.
113. Duval, D., Trouillas, M., Thibault, C., Dembelé, D., Diemunsch, F., Reinhardt, B., et al. (2006). Apoptosis and differentiation commitment: novel insights revealed by gene profiling studies in mouse embryonic stem cells. Cell Death and Differentiation, 13(4), 564-575.
114. Boeuf, H., Merienne, K., Jacquot, S., Duval, D., Zeniou, M., Hauss, C., et al. (2001). The ribosomal S6 kinases, cAMP-responsive element-binding, and STAT3 proteins are regulated by different leukemia inhibitory factor signaling pathways in mouse embryonic stem cells. The Journal of Biological Chemistry, 276(49), 46204-46211.
115. Li, Y., McClintick, J., Zhong, L., Edenberg, H. J., Yoder, M. C., & Chan, R. J. (2005). Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood, 105(2), 635-637.
116. Jiang, J., Chan, Y., Loh, Y., Cai, J., Tong, G., Lim, C., et al. (2008). A core Klf circuitry regulates self-renewal of embryonic stem cells. Nature Cell Biology, 10(3), 353-360.
117. Niwa, H., Ogawa, K., Shimosato, D., & Adachi, K. (2009). A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature, 460(7251), 118-122.
118. Parisi, S., Passaro, F., Aloia, L., Manabe, I., Nagai, R., Pastore, L., et al. (2008). Klf5 is involved in self-renewal of mouse embryonic stem cells. Journal of Cell Science, 121(Pt 16), 2629-2634.
119. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663-676.
120. Zhang, P., Andrianakos, R., Yang, Y., Liu, C., & Lu, W. (2010). Kruppel-like factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression. The Journal of Biological Chemistry, 285(12), 9180-9189.
121. Hall, J., Guo, G., Wray, J., Eyres, I., Nichols, J., Grotewold, L., et al. (2009). Oct4 and LIF/Stat3 additively induce Krüppel factors to sustain embryonic stem cell self-renewal. Cell Stem Cell, 5(6), 597-609.
122. Moreau, J. F., Bonneville, M., Godard, A., Gascan, H., Gruart, V., Moore, M. A., et al. (1987). Characterization of a factor produced by human T cell clones exhibiting eosinophil-activating and burst-promoting activities. Journal of Immunology, 138(11), 3844-3849.
123. Dührsen, U., & Metcalf, D. (1988). A model system for leukemic transformation of immortalized hemopoietic cells in irradiated recipient mice. Leukemia, 2(6), 329-333.
124. Leary, A. G., Wong, G. G., Clark, S. C., Smith, A. G., & Ogawa, M. (1990). Leukemia inhibitory factor differentiation-inhibiting activity/human interleukin for DA cells augments proliferation of human hematopoietic stem cells. Blood, 75(10), 1960-1964.
125. Verfaillie, C., & McGlave, P. (1991). Leukemia inhibitory factor/human interleukin for DA cells: a growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors. Blood, 77(2), 263-270.
126. Metcalf, D., & Gearing, D. P. (1989). Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proceedings of the National Academy of Sciences of the United States of America, 86(15), 5948-5952.
127. Metcalf, D., Nicola, N. A., & Gearing, D. P. (1990). Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice. Blood, 76(1), 50-56.
128. Ware, C. B., Horowitz, M. C., Renshaw, B. R., Hunt, J. S., Liggitt, D., Koblar, S. A., et al. (1995). Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development, 121(5), 1283-1299.
129. Dagoneau, N., Scheffer, D., Huber, C., Al-Gazali, L. I., Di Rocco, M., Godard, A., et al. (2004). Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome. American Journal of Human Genetics, 74(2), 298-305.
130. García-Gómez, I., Elvira, G., Zapata, A. G., Lamana, M. L., Ramírez, M., Castro, J. G., et al. (2010). Mesenchymal stem cells: biological properties and clinical applications. Expert Opinion on Biological Therapy, 10(10), 1453-1468.
131. Lorgeot, V., Rougier, F., Fixe, P., Cornu, E., Praloran, V., & Denizot, Y. (1997). Spontaneous and inducible production of leukaemia inhibitory factor by human bone marrow stromal cells. Cytokine, 9(10), 754-758.
132. Metcalfe, S. M. (2005). Axotrophin and leukaemia inhibitory factor (LIF) in transplantation tolerance. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 360, 1687-1694.
133. Nasef, A., Mazurier, C., Bouchet, S., Francois, S., Chapel, A., Thierry, D., et al. (2008). Leukemia inhibitory factor: role in human mesenchymal stem cells mediated immunosuppression. Cellular Immunology, 253, 16-22.
134. Szilvassy, S. J., Weller, K. P., Chen, B., Juttner, C. A., Tsukamoto, A., & Hoffman, R. (1996). Partially differentiated ex vivo expanded cells accelerate hematologic recovery in myeloablated mice transplanted with highly enriched long-term repopulating stem cells. Blood, 88(9), 3642-3653.
135. Schraml, E., Fehrer, C., Brunauer, R., Lepperdinger, G., Chesnokova, V., & Schauenstein, K. (2008). lin-Sca-1+ cells and age-dependent changes of their proliferation potential are reliant on mesenchymal stromal cells and are leukemia inhibitory factor dependent. Gerontology, 54(5), 312-323.
136. Dhawan, J., & Rando, T. A. (2005). Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends in Cell Biology, 15(12), 666-673.
137. Montarras, D., Morgan, J., Collins, C., Relaix, F., Zaffran, S., Cumano, A., et al. (2005). Direct isolation of satellite cells for skeletal muscle regeneration. Science, 309(5743), 2064-2067.
138. Buckingham, M., & Montarras, D. (2008). Skeletal muscle stem cells. Current Opinion in Genetics & Development, 18(4), 330-336.
139. Austin, L., & Burgess, A. W. (1991). Stimulation of myoblast proliferation in culture by leukaemia inhibitory factor and other cytokines. Journal of the Neurological Sciences, 101(2), 193-197.
140. Barnard, W., Bower, J., Brown, M. A., Murphy, M., & Austin, L. (1994). Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: injured muscle expresses lif mRNA. Journal of the Neurological Sciences, 123, 108-113.
141. Diao, Y., Wang, X., & Wu, Z. (2009). SOCS1, SOCS3, and PIAS1 promote myogenic differentiation by inhibiting the leukemia inhibitory factor-induced JAK1/STAT1/STAT3 pathway. Molecular and Cellular Biology, 29(18), 5084-5093.
142. Yang, Y., Xu, Y., Li, W., Wang, G., Song, Y., Yang, G., et al. (2009). STAT3 induces muscle stem cell differentiation by interaction with myoD. Cytokine, 46(1), 137-141.
143. Spangenburg, E. E., & Booth, F. W. (2006). Leukemia inhibitory factor restores the hypertrophic response to increased loading in the LIF(-/-) mouse. Cytokine, 34(3-4), 125-130.
144. Gearing, D. P., Ziegler, S. F., Comeau, M. R., Friend, D., Thoma, B., Cosman, D., et al. (1994). Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor. Proceedings of the National Academy of Sciences of the United States of America, 91(3), 1119-1123.
145. Bazan, E., Alonso, F. J., Redondo, C., Lopez-Toledano, M. A., Alfaro, J. M., Reimers, D., et al. (2004). In vitro and in vivo characterization of neural stem cells. Histology and Histopathology, 19, 1261-1275.
146. Abrous, D. N., Koehl, M., & Le Moal, M. (2005). Adult neurogenesis: from precursors to network and physiology. Physiological Reviews, 85(2), 523-569.
147. Suh, H., Deng, W., & Gage, F. H. (2009). Signaling in adult neurogenesis. Annual Review of Cell and Developmental Biology, 25, 253-275.
148. Andersen, R. K., Zimmer, J., Wahlberg, L. U., & Meyer, M. (2008). Effect of leukemia inhibitory factor on long-term propagation of precursor cells derived from rat forebrain subventricular zone and ventral mesencephalon. Experimental Neurology, 211(1), 301-310.
149. Müller, S., Chakrapani, B. P. S., Schwegler, H., Hofmann, H., & Kirsch, M. (2009). Neurogenesis in the dentate gyrus depends on ciliary neurotrophic factor and signal transducer and activator of transcription 3 signaling. Stem Cells, 27(2), 431-441.
150. Sun, Y., Pollard, S., Conti, L., Toselli, M., Biella, G., Parkin, G., et al. (2008). Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. Molecular and Cellular Neurosciences, 38(2), 245-258.
151. Covey, M. V., & Levison, S. W. (2007). Leukemia inhibitory factor participates in the expansion of neural stem/progenitors after perinatal hypoxia/ischemia. Neuroscience, 148(2), 501-509.
152. Ishibashi, T., Lee, P. R., Baba, H., & Fields, R. D. (2009). Leukemia inhibitory factor regulates the timing of oligodendrocyte development and myelination in the postnatal optic nerve. Journal of Neuroscience Research, 87(15), 3343-3355.
153. Yamanaka, S. (2010). Patient-specific pluripotent stem cells become even more accessible. Cell Stem Cell, 7(1), 1-2.
154. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5), 861-872.
155. Elefanty, A. G., Blelloch, R., Passegué, E., Wernig, M., & Mummery, C. L. (2010). On the streets of San Francisco: highlights from the ISSCR Annual Meeting 2010. Cell Stem Cell, 7(4), 443-450.
156. Yoshida, Y., Takahashi, K., Okita, K., Ichisaka, T., & Yamanaka, S. (2009). Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell, 5(3), 237-241.
157. Zhao, T., & Xu, Y. (2010). p53 and stem cells: new developments and new concerns. Trends in Cell Biology, 20(3), 170-175.
158. Cotterman, R., & Knoepfler, P. S. (2009). N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b. PLoS ONE, 4(6), e5799.
159. Auernhammer, C. J., & Melmed, S. (2000). Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocrine Reviews, 21(3), 313-345.
160. Brivanlou, A. H., & Darnell, J. E. (2002). Signal transduction and the control of gene expression. Science, 295(5556), 813-818.
161. Pires-daSilva, A., & Sommer, R. J. (2003). The evolution of signalling pathways in animal development. Nature Reviews. Genetics, 4(1), 39-49.
162. Huising, M. O., Kruiswijk, C. P., & Flik, G. (2006). Phylogeny and evolution of class-I helical cytokines. The Journal of Endocrinology, 189(1), 1-25.
163. Hombría, J. C. G., & Brown, S. (2002). The fertile field of Drosophila Jak/STAT signalling. Current Biology, 12(16), R569-R575.
164. Horiuchi, H., Furusawa, S., & Matsuda, H. (2006). Maintenance of chicken embryonic stem cells in vitro. Methods in Molecular Biology, 329, 17-34.
165. Fujiki, K., Nakao, M., & Dixon, B. (2003). Molecular cloning and characterisation of a carp (Cyprinus carpio) cytokine-like cDNA that shares sequence similarity with IL-6 subfamily cytokines CNTF, OSM and LIF. Developmental and Comparative Immunology, 27(2), 127-136.
166. Abe, T., Mikekado, T., Haga, S., Kisara, Y., Watanabe, K., Kurokawa, T., et al. (2007). Identification, cDNA cloning, and mRNA localization of a zebrafish ortholog of leukemia inhibitory factor. Comparative Biochemistry and Physiology. Part B: Biochemistry & Molecular Biology, 147(1), 38-44.
167. Hanington, P. C., & Belosevic, M. (2007). Interleukin-6 family cytokine M17 induces differentiation and nitric oxide response of goldfish (Carassius auratus L.) macrophages. Developmental and Comparative Immunology, 31(8), 817-829.
168. Duong, C. V., Geissen, M., & Rohrer, H. (2002). The developmental expression of vasoactive intestinal peptide (VIP) in cholinergic sympathetic neurons depends on cytokines signaling through LIFRbeta-containing receptors. Development, 129(6), 1387-1396.
169. Hanington, P. C., Patten, S. A., Reaume, L. M., Waskiewicz, A. J., Belosevic, M., & Ali, D. W. (2008). Analysis of leukemia inhibitory factor and leukemia inhibitory factor receptor in embryonic and adult zebrafish (Danio rerio). Developmental Biology, 314(2), 250-260.
170. Nishinakamura, R., Matsumoto, Y., Matsuda, T., Ariizumi, T., Heike, T., Asashima, M., et al. (1999). Activation of Stat3 by cytokine receptor gp130 ventralizes Xenopus embryos independent of BMP-4. Developmental Biology, 216(2), 481-490.
171. Nichane, M., Ren, X., & Bellefroid, E. J. (2010). Self-regulation of Stat3 activity coordinates cell-cycle progression and neural crest specification. The EMBO Journal, 29(1), 55-67.
172. Brons, I. G., Smithers, L. E., Trotter, M. W., Rugg-Gunn, P., Sun, B., Lopes, S. M. C. D. S., et al. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature, 448, 191-195.
173. Tesar, P. J., Chenoweth, J. G., Brook, F. A., Davies, T. J., Evans, E. P., Mack, D. L., et al. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature, 448, 196-199.
174. Bao, S., Tang, F., Li, X., Hayashi, K., Gillich, A., Lao, K., et al. (2009). Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells. Nature, 461, 1292-1295.
175. Guo, G., Yang, J., Nichols, J., Hall, J. S., Eyres, I., Mansfield, W., et al. (2009). Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development, 136, 1063-1069.
176. De Matos, D. G., Miller, K., Scott, R., Tran, C. A., Kagan, D., Nataraja, S. G., et al. (2008). Leukemia inhibitory factor induces cumulus expansion in immature human and mouse oocytes and improves mouse two-cell rate and delivery rates when it is present during mouse in vitro oocyte maturation. Fertility and Sterility, 90, 2367-2375.
177. Kanatsu-Shinohara, M., Inoue, K., Ogonuki, N., Miki, H., Yoshida, S., Toyokuni, S., et al. (2007). Leukemia inhibitory factor enhances formation of germ cell colonies in neonatal mouse testis culture. Biology of Reproduction, 76, 55-62.
178. Marwood, M., Visser, K., Salamonsen, L. A., & Dimitriadis, E. (2009). Interleukin-11 and leukemia inhibitory factor regulate the adhesion of endometrial epithelial cells: implications in fertility regulation. Endocrinology, 150, 2915-2923.
179. Mikhaylova, I. V., Jääskeläinen, T., Jääskeläinen, J., Palvimo, J. J., & Voutilainen, R. (2008). Leukemia inhibitory factor as a regulator of steroidogenesis in human NCI-H295R adrenocortical cells. The Journal of Endocrinology, 199, 435-444.
180. Metcalf, D., Hilton, D., & Nicola, N. A. (1991). Leukemia inhibitory factor can potentiate murine megakaryocyte production in vitro. Blood, 77, 2150-2153.
181. Nasef, A., Mazurier, C., Bouchet, S., François, S., Chapel, A., Thierry, D., et al. (2008). Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. Cellular Immunology, 253, 16-22.
182. Sun, L., Ma, K., Wang, H., Xiao, F., Gao, Y., Zhang, W., et al. (2007). JAK1-STAT1-STAT3, a key pathway promoting proliferation and preventing premature differentiation of myoblasts. The Journal of Cell Biology, 179, 129-138.
183. Alter, J., Rozentzweig, D., & Bengal, E. (2008). Inhibition of myoblast differentiation by tumor necrosis factor alpha is mediated by c-Jun N-terminal kinase 1 and leukemia inhibitory factor. The Journal of Biological Chemistry, 283, 23224-23234.
184. Paradis, H., & Gendron, R. L. (2000). LIF transduces contradictory signals on capillary outgrowth through induction of stat3 and (P41/43)MAP kinase. Journal of Cell Science, 113(Pt 23), 4331-4339.
185. Murphy, M., Reid, K., Hilton, D. J., & Bartlett, P. F. (1991). Generation of sensory neurons is stimulated by leukemia inhibitory factor. Proceedings of the National Academy of Sciences of the United States of America, 88, 3498-3501.
186. Andersen, R. K., Widmer, H. R., Zimmer, J., Wahlberg, L. U., & Meyer, M. (2009). Leukemia inhibitory factor favours neurogenic differentiation of long-term propagated human midbrain precursor cells. Neuroscience Letters, 464, 203-208.
187. Carter, D. A., Dick, A. D., & Mayer, E. J. (2009). CD133+ adult human retinal cells remain undifferentiated in Leukaemia Inhibitory Factor (LIF). BMC Ophthalmology, 9, 1.
188. Chen, H., Ma, H., Sytwu, H., Wang, H., Chen, C. V., Liu, S., et al. (2010). Neural stem cells secrete factors that promote auditory cell proliferation via a leukemia inhibitory factor signaling pathway. Journal of Neuroscience Research, 88(15), 3308-3318.
189. Barasch, J., Yang, J., Ware, C. B., Taga, T., Yoshida, K., Erdjument-Bromage, H., et al. (1999). Mesenchymal to epithelial conversion in rat metanephros is induced by LIF. Cell, 99, 377-386.
190. Kanda, J., Uchiyama, T., Tomosugi, N., Higuchi, M., Uchiyama, T., & Kawabata, H. (2009). Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines. International Journal of Hematology, 90, 545-552.
191. Lumaki, F., Basso, S. M., Orlando, R. (2010). Cytokines, thyroid diseases and thyroid cancer. Cytokine, 50(3), 299-233.
192. Quaglino, A., Schere-Levy, C., Romorini, L., Meiss, R. P., & Kordon, E. C. (2007). Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling. Breast Cancer Research, 9, R69.
193. Wysoczynski, M., Miekus, K., Jankowski, K., Wanzeck, J., Bertolone, S., Janowska-Wieczorek, A., et al. (2007). Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas. Cancer Research, 67, 2131-2140.
194. McKenzie, R. C., & Szepietowski, J. (2004). Cutaneous leukemia inhibitory factor and its potential role in the development of skin tumors. Dermatologic Surgery, 30, 279-290.
195. Maruta, S., Takiguchi, S., Ueyama, M., Kataoka, Y., Oda, Y., Tsuneyoshi, M., et al. (2009). A role for leukemia inhibitory factor in melanoma-induced bone metastasis. Clinical & Experimental Metastasis, 26, 133-141.
196. Peñuelas, S., Anido, J., Prieto-Sánchez, R. M., Folch, G., Barba, I., Cuartas, I., et al. (2009). TGF-[beta] Increases Glioma-Initiating Cell Self-Renewal through the Induction of LIF in Human Glioblastoma. Cancer Cell, 15, 315-327.
197. Kurek, J. B., Bower, J. J., Romanella, M., Koentgen, F., Murphy, M., & Austin, L. (1997). The role of leukemia inhibitory factor in skeletal muscle regeneration. Muscle Nerve. Muscle & Nerve, 20, 815-822.
198. Kubota, Y., Hirashima, M., Kishi, K., Stewart, C. L., & Suda, T. (2008). Leukemia inhibitory factor regulates microvessel density by modulating oxygen-dependent VEGF expression in mice. Journal of Clinical Investigation, 118, 2393-2403.
199. Bozec, A., Bakiri, L., Hoebertz, A., Eferl, R., Schilling, A. F., Komnenovic, V., et al. (2008). Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature. Nature, 454, 221-225.
200. Sugiura, S., Lahav, R., Han, J., Kou, S. Y., Banner, L. R., de Pablo, F., et al. (2000). Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro. The European Journal of Neuroscience, 12, 457-466.
201. Bugga, L., Gadient, R. A., Kwan, K., Stewart, C. L., & Patterson, P. H. (1998). Analysis of neuronal and glial phenotypes in brains of mice deficient in leukemia inhibitory factor. Journal of Neurobiology, 36, 509-524.
202. Marriott, M. P., Emery, B., Cate, H. S., Binder, M. D., Kemper, D., Wu, Q., et al. (2008). Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair. Glia, 56, 686-698.
203. Cohen, J. E., & Fields, R. D. (2008). Activity-dependent neuron-glial signaling by ATP and leukemiainhibitory factor promotes hippocampal glial cell development. Neuron Glia Biology, 4, 43-55.
204. Bürgi, S., Samardzija, M., & Grimm, C. (2009). Endogenous leukemia inhibitory factor protects photoreceptor cells against light-induced degeneration. Molecular Vision, 15, 1631-1637.
205. Kirsch, M., Trautmann, N., Ernst, M., & Hofmann, H. (2010). Involvement of gp130-associated cytokine signaling in Müller cell activation following optic nerve lesion. Glia, 58, 768-779.
206. Bauer, S., Rasika, S., Han, J., Mauduit, C., Raccurt, M., Morel, G., et al. (2003). Leukemia inhibitory factor is a key signal for injury-induced neurogenesis in the adult mouse olfactory epithelium. The Journal of Neuroscience, 23, 1792-1803.
207. Banner, L. R., Patterson, P. H., Allchorne, A., Poole, S., & Woolf, C. J. (1998). Leukemia inhibitory factor is an anti-inflammatory and analgesic cytokine. The Journal of Neuroscience, 18, 5456-5462.
208. Chesnokova, V., Kariagina, A., & Melmed, S. (2002). Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation. American Journal of Physiology. Endocrinology and Metabolism, 282, E1110-E1118.